Apertura Gene Therapy and the TSC Alliance Announce Collaboration to Advance Gene Therapy Programs Designed to Treat Tuberous Sclerosis Complex (TSC)

B — Gene therapy programs developed through the collaboration will use Apertura’s TfR1 CapX™, a novel, intravenously delivered AAV capsid — NEW YORK AND SILVER…
posteditor
posteditor
Articles: 21727

Other News